Becton Dickinson & Co. (BDX) Stock Price and Analyst Predictions

Becton Dickinson & Co. (NYSE: BDX) has a price-to-earnings ratio that is above its average at 54.92x. The stock has a 36-month beta value of 0.46. Opinions on the stock are mixed, with 3 analysts rating it as a “buy,” 7 as “overweight,” 5 as “hold,” and 0 as “sell.”

The public float for BDX is 288.48M, and at present, short sellers hold a 1.01% of that float. On April 18, 2024, the average trading volume of BDX was 1.36M shares.

BDX) stock’s latest price update

Becton Dickinson & Co. (NYSE: BDX) has seen a rise in its stock price by 0.52 in relation to its previous close of 231.01. However, the company has experienced a -3.64% decline in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-04-12 that BD’s (BDX) slew of product launches and strategic deals raises optimism about the stock.

BDX’s Market Performance

BDX’s stock has fallen by -3.64% in the past week, with a monthly drop of -2.32% and a quarterly drop of -0.89%. The volatility ratio for the week is 1.80% while the volatility levels for the last 30 days are 1.71% for Becton Dickinson & Co. The simple moving average for the past 20 days is -3.88% for BDX’s stock, with a -7.67% simple moving average for the past 200 days.

Analysts’ Opinion of BDX

Many brokerage firms have already submitted their reports for BDX stocks, with Raymond James repeating the rating for BDX by listing it as a “Outperform.” The predicted price for BDX in the upcoming period, according to Raymond James is $305 based on the research report published on July 24, 2023 of the previous year 2023.

Morgan Stanley, on the other hand, stated in their research note that they expect to see BDX reach a price target of $295. The rating they have provided for BDX stocks is “Overweight” according to the report published on May 30th, 2023.

Piper Sandler gave a rating of “Overweight” to BDX, setting the target price at $290 in the report published on May 05th of the previous year.

BDX Trading at -3.32% from the 50-Day Moving Average

After a stumble in the market that brought BDX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -19.18% of loss for the given period.

Volatility was left at 1.71%, however, over the last 30 days, the volatility rate increased by 1.80%, as shares sank -3.34% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.22% lower at present.

During the last 5 trading sessions, BDX fell by -3.64%, which changed the moving average for the period of 200-days by -12.04% in comparison to the 20-day moving average, which settled at $241.17. In addition, Becton Dickinson & Co. saw -4.77% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at BDX starting from Spoerel Thomas J, who sale 282 shares at the price of $238.29 back on Mar 14 ’24. After this action, Spoerel Thomas J now owns 2,276 shares of Becton Dickinson & Co., valued at $67,198 using the latest closing price.

Garrison Michael David, the EVP & President Medical of Becton Dickinson & Co., sale 1,239 shares at $232.46 during a trade that took place back on Dec 11 ’23, which means that Garrison Michael David is holding 7,274 shares at $288,018 based on the most recent closing price.

Stock Fundamentals for BDX

Current profitability levels for the company are sitting at:

  • 0.1 for the present operating margin
  • 0.41 for the gross margin

The net margin for Becton Dickinson & Co. stands at 0.06. The total capital return value is set at 0.04. Equity return is now at value 5.13, with 2.47 for asset returns.

Based on Becton Dickinson & Co. (BDX), the company’s capital structure generated 0.39 points at debt to capital in total, while cash flow to debt ratio is standing at 0.21. The debt to equity ratio resting at 0.64. The interest coverage ratio of the stock is 8.19.

Currently, EBITDA for the company is 4.71 billion with net debt to EBITDA at 3.77. When we switch over and look at the enterprise to sales, we see a ratio of 4.21. The receivables turnover for the company is 8.6for trailing twelve months and the total asset turnover is 0.37. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.08.

Conclusion

To sum up, Becton Dickinson & Co. (BDX) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts